🇺🇸 FDA

Intelligence · Patent portfolio

United Therapeutics Europe Patents

Full USPTO pharma patent portfolio for United Therapeutics Europe — grant dates, expiration, and drug cross-links.

Patents
3,720
Expiring ≤24m
234

Quick answer

United Therapeutics Europe has 3,720 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 234 expire within 24 months — use filters for patent-cliff planning.

Page 47 of 78

  1. US 8357525

    Thermal inactivation of rotavirus

    Expires Mon Jan 17 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 8354115

    CD40 ligand adjuvant for respiratory syncytial virus

    Expires Mon Jan 10 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 8354390

    Compositions and methods for inhibiting expression of a gene from the ebola virus

    Expires Mon Jan 10 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 8349892

    Solid formulations of prostacyclin analogs

    Expires Mon Jan 03 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 8349568

    Method of diagnosing poor survival prognosis colon cancer using let-7g

    Expires Mon Jan 03 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 8349586

    Commensal strain of E. coli encoding an HIV GP41 protein

    Expires Mon Jan 03 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 8349888

    Phytoestrogenic isoflavone compositions, their preparation and use thereof for protection against and treatment of radiation injury

    Expires Mon Jan 03 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 8350079

    Treprostinil formulation

    Expires Mon Jan 03 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 8343725

    Method of diagnosing poor survival prognosis colon cancer using miR-10a

    Expires Mon Dec 27 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 8344019

    Methods for the production of biliverdin

    Expires Mon Dec 27 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 8343499

    Anti-arthropod vector vaccines, methods of selecting and uses thereof

    Expires Mon Dec 27 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 8338104

    Method of diagnosing poor survival prognosis colon cancer using miR-103-2

    Expires Mon Dec 20 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 8338457

    Selective ablation of pain-sensing neurons by administration of a vanilloid receptor agonist

    Expires Mon Dec 20 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 8338106

    Method of diagnosing poor survival prognosis colon cancer using miR-29a

    Expires Mon Dec 20 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 8338105

    Method of diagnosing poor survival prognosis colon cancer using miR-203

    Expires Mon Dec 20 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 8338103

    Method of diagnosing poor survival prognosis colon cancer using miR-106a

    Expires Mon Dec 20 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 8337860

    Development of dengue virus vaccine components

    Expires Mon Dec 20 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 8337854

    Monoclonal antibodies against dengue and other viruses with deletion in Fc region

    Expires Mon Dec 20 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 8337853

    Monoclonal antibodies that bind or neutralize dengue virus

    Expires Mon Dec 20 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 8337832

    Vaccine for protection against Shigella sonnei disease

    Expires Mon Dec 20 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 8337831

    Live, oral vaccine for protection against Shigella dysenteriae serotype 1

    Expires Mon Dec 20 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 8338102

    Method of diagnosing poor survival prognosis colon cancer using miR-181b

    Expires Mon Dec 20 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 8334260

    sFRP and peptide motifs that interact with sFRP and methods of their use

    Expires Mon Dec 13 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 8323706

    Antiestrogenic glyceollins suppress human breast and ovarian carcinoma proliferation and tumorigenesis

    Expires Mon Nov 29 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 8323961

    HIV vaccines based on adenoviral vectors encoding Env from multiple clades of HIV

    Expires Mon Nov 29 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 8318183

    Plasmodium liver stage antigens

    Expires Mon Nov 22 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 8318666

    Use of leptin to treat metabolic abnormalities associated with lipoatrophy

    Expires Mon Nov 22 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 8318177

    Viral chemokine-antigen fusion proteins

    Expires Mon Nov 22 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 8318425

    Inhibition of HIV-1 replication by disruption of the processing of the viral capsid-spacer peptide 1 protein

    Expires Mon Nov 22 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 8313789

    Methods of promoting the growth of beneficial bacteria in the gut

    Expires Mon Nov 15 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 8313746

    Human monoclonal antibodies against hendra and nipah viruses

    Expires Mon Nov 15 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 8309701

    Variants of human taste receptor genes

    Expires Mon Nov 08 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 8309527

    Immunomodulatory oligonucleotides

    Expires Mon Nov 08 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 8303960

    Radiolabeled affibody molecules

    Expires Mon Nov 01 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 8298523

    Compositions containing interleukin-1 and peptides

    Expires Mon Oct 25 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 8298541

    Live attenuated virus vaccines for La Crosse virus and other Bunyaviridae

    Expires Mon Oct 25 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 8298546

    Isolation and purification of P. falciparum merozoite protein-142 vaccine

    Expires Mon Oct 25 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 8299050

    Method for treating uterine fibroids

    Expires Mon Oct 25 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 8298525

    Method of treating multiple sclerosis with interferon-beta and an IL-2R antagonist

    Expires Mon Oct 25 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 8293800

    Quinone derivative 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone for the treatment of primary progressive multiple sclerosis

    Expires Mon Oct 18 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 8293724

    Therapeutic applications of fatty acid amide hydrolase inhibitors

    Expires Mon Oct 18 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 8288439

    Methods and compositions for the inhibition of HIV-1 replication

    Expires Mon Oct 11 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 8287857

    Immunotherapy with in vitro-selected antigen-specific lymphocytes after nonmyeloablative lymphodepleting chemotherapy

    Expires Mon Oct 11 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 8288359

    Method of treating inflammatory arthropathies with suppressors of CpG oligonucleotides

    Expires Mon Oct 11 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 8288530

    Method of preparing macromolecular contrast agents and uses thereof

    Expires Mon Oct 11 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 8287876

    Recombinant chimeric antigens for diagnosis and prevention of scrub typhus

    Expires Mon Oct 11 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 8282926

    CCR5-specific antibodies with HIV neutralizing activity that recognize a linear dodecapeptide that mimics a conformational epitope in the second extracellular loop of CCR5

    Expires Mon Oct 04 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 8283370

    Imidazolidinedione derivatives as antimalarial agents, preparation thereof, and methods of use

    Expires Mon Oct 04 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does United Therapeutics Europe have?

3,720 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do United Therapeutics Europe patents expire?

234 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Where does this data come from?

USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.

Data attribution: Data sources · Patent directory

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.